Cited by — Abstract No: 053 ABERRANT SYK METHYLATION PARTICIPATES IN BCR SIGNALING REMODELING AND AFFECT LONG-TERM OUTCOMES OF GLUCOCORTICOID THERAPY IN MINIMAL CHANGE DISEASE | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Abstract No: 053 ABERRANT SYK METHYLATION PARTICIPATES IN BCR SIGNALING REMODELING AND AFFECT LONG-TERM OUTCOMES OF GLUCOCORTICOID THERAPY IN MINIMAL CHANGE DISEASE.
No admitted local citation edges point to this work yet.
